The relationship between bipolar disorder and type 2 diabetes: more than just co-morbid disorders (Q38012489)

27 August 2017

The relationship between bipolar disorder and type 2 diabetes: more than just co-morbid disorders (English)

1 reference

27 August 2017

1 reference

1 reference

Cynthia V Calkin

1

1 reference

27 August 2017

David M Gardner

series ordinal

2

1 reference

27 August 2017

Thomas Ransom

series ordinal

3

1 reference

27 August 2017

Martin Alda

series ordinal

4

1 reference

27 August 2017

language of work or name

English

0 references

publication date

24 May 2012

1 reference

27 August 2017

1 reference

27 August 2017

45

1 reference

27 August 2017

2

1 reference

27 August 2017

171-181

1 reference

The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases

27 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Psychosocial disability and work role function compared across the long-term course of bipolar I, bipolar II and unipolar major depressive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Excess mortality in bipolar and unipolar disorder in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Bipolar disorder and diabetes mellitus: epidemiology, etiology, and treatment implications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Improving medical and psychiatric outcomes among individuals with bipolar disorder: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

The effects of undertreated chronic medical illnesses in patients with severe mental disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Disparities in hospitalization for diabetes among persons with and without co-occurring mental disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Stress and glucocorticoid.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

The dexamethasone/corticotropin-releasing hormone test in depression in bipolar and unipolar affective illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Is elevated noradrenaline an aetiological factor in a number of diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Possible connections between stress, diabetes, obesity, hypertension and altered lipoprotein metabolism that may result in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

The effects of cortisol on insulin sensitivity in muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Mitochondrial dysfunction in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Muscle mitochondrial ATP synthesis and glucose transport/phosphorylation in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

The role of mitochondrial dysfunction in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

The role of mitochondria in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Lithium-induced enhancement of mitochondrial oxidative phosphorylation in human brain tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

The anti-apoptotic, glucocorticoid receptor cochaperone protein BAG-1 is a long-term target for the actions of mood stabilizers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Schizophrenia as a GSK-3 dysregulation disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

GSK-3 is a viable potential target for therapeutic intervention in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Depression and bipolar disorder: relationships to impaired fatty acid and phospholipid metabolism and to diabetes, cardiovascular disease, immunological abnormalities, cancer, ageing and osteoporosis. Possible candidate genes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Pathway analysis of seven common diseases assessed by genome-wide association

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Genetic and metabolic characterization of insomnia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Epigenetic programming of stress responses through variations in maternal care

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Epigenetic programming by maternal behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Neurobiological effects of childhood abuse: implications for the pathophysiology of depression and anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Prevalence and clinical impact of childhood trauma in patients with severe mental disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Impact of childhood abuse on the clinical course of bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Childhood trauma and hallucinations in bipolar affective disorder: preliminary investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Childhood abuse and diabetes in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Adverse childhood experiences and adult risk factors for age-related disease: depression, inflammation, and clustering of metabolic risk markers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Elevated inflammation levels in depressed adults with a history of childhood maltreatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Childhood maltreatment predicts adult inflammation in a life-course study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Biological embedding of stress through inflammation processes in childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Investigation of serum high-sensitive C-reactive protein levels across all mood states in bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

The pathophysiologic roles of interleukin-6 in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Can body mass index help predict outcome in patients with bipolar disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Psychotropic drugs induced weight gain: a review of the literature concerning epidemiological data, mechanisms and management

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Side effects of atypical antipsychotics: extrapyramidal symptoms and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Association between HTR2C and HTR2A polymorphisms and metabolic abnormalities in patients treated with olanzapine or clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Impact of serotonin receptor 2A gene haplotypes on C-peptide levels in clozapine- and olanzapine-treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

The association of olanzapine-induced weight gain with peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism in patients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Inhibition of glucose transport in PC12 cells by the atypical antipsychotic drugs risperidone and clozapine, and structural analogs of clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Antipsychotic drugs affect glucose uptake and the expression of glucose transporters in PC12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

The incidence of diabetes in atypical antipsychotic users differs according to agent--results from a multisite epidemiologic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Effects of psychotropics on glycosylated hemoglobin (HbA1c) in a cohort of bipolar patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Assessment of antipsychotic-related risk of diabetes mellitus in a Medicaid psychosis population: sensitivity to study design

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Sodium-lithium countertransport and platelet cytosolic free calcium concentration in relation to peripheral insulin sensitivity in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Transient diabetes associated with withdrawal of lithium therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Does long-term lithium treatment induce diabetes mellitus?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Polycystic ovary syndrome in women using valproate: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Weight gain following treatment with valproic acid: pathogenetic mechanisms and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Bodyweight gain and anticonvulsants: a comparative review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Carbohydrate metabolism in brain disease. II. Glucose metabolism in Schizophrenic, manic-depressive, and involutional psychoses.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Clinical features of bipolar disorder with and without comorbid diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Medical comorbidity in bipolar disorder: relationship between illnesses of the endocrine/metabolic system and treatment outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Rosiglitazone add-on in treatment of depressed patients with insulin resistance: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Clinical and health services relationships between major depression, depressive symptoms, and general medical illness

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

The association of comorbid depression with intensive care unit admission in patients with diabetes: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

The association of comorbid depression with mortality in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Diabetes and poor disease control: is comorbid depression associated with poor medication adherence or lack of treatment intensification?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Relationship of depression and diabetes self-care, medication adherence, and preventive care

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Depression and incident diabetic foot ulcers: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Depression and incident diabetic retinopathy: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Comorbid depression is associated with an increased risk of dementia diagnosis in patients with diabetes: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Depression and advanced complications of diabetes: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Depression and increased mortality in diabetes: unexpected causes of death

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Association of major depression and mortality in Stage 5 diabetic chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Disparities in diabetes care: impact of mental illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Quality of diabetes care among adults with serious mental illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Chronic somatic comorbidity and excess mortality due to natural causes in persons with schizophrenia or bipolar affective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

A randomized trial of medical care management for community mental health settings: the Primary Care Access, Referral, and Evaluation (PCARE) study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Management of antipsychotic-induced weight gain: prospective naturalistic study of the effectiveness of a supervised exercise programme

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Metformin for atypical antipsychotic-induced weight gain and glucose metabolism dysregulation: review of the literature and clinical suggestions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Metformin for olanzapine-induced weight gain: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Metformin addition attenuates olanzapine-induced weight gain in drug-naive first-episode schizophrenia patients: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

The effect of metformin on anthropometrics and insulin resistance in patients receiving atypical antipsychotic agents: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Efficacy of metformin and topiramate in prevention and treatment of second-generation antipsychotic-induced weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Exercise as a treatment for depression and other psychiatric disorders: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

The effects of physical activity in the acute treatment of bipolar disorder: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Exercise treatment for bipolar disorder: potential mechanisms of action mediated through increased neurogenesis and decreased allostatic load

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Aerobic physical exercise as a possible treatment for neurocognitive dysfunction in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Links between cognitive impairment in insulin resistance: an explanatory model.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Reduced glucose tolerance is associated with poor memory performance and hippocampal atrophy among normal elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Long-term effects of intensive glucose lowering on cardiovascular outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Rosiglitazone revisited: an updated meta-analysis of risk for myocardial infarction and cardiovascular mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Metformin's contraindications should be contraindicated.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Five-year follow-up of a cohort of people with their first diabetic foot ulcer: the persistent effect of depression on mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2012.687835

Metformin monotherapy for type 2 diabetes mellitus

21 January 2018

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD002966.PUB3

Identifiers

DOI

10.3109/07853890.2012.687835

1 reference

27 August 2017

1 reference